Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL

NCT02212379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: raltegravir and etravirine

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]